Clinical Evaluation of Safety and Efficacy of Vedistry Arjuna + Tablet in Hyperlipidemia

Objective: To establish the efficacy and safety of Vedistry Arjuna + Tablet in the management of hyperlipidemia. Methods: A randomized, double blind, active controlled, single center, clinical study was carried out using Vedistry Arjuna + Tablet for the duration of 12 weeks in 300 patients with hyperlipidemia and chronic stable angina. Results: The results showed that Vedistry Arjuna + Tablet and Simvastatin both produced significant reduction of cholesterol and triglycerides. In addition, the group receiving Vedistry Arjuna + Tablet reported significant improvements in the stress test parameters compared to those receiving Simvastatin. Low incidences of side-effects in the Vedistry Arjuna + Tablet receiving group compared to Simvastatin receiving group indicates that Arjuna would be a safer alternative. Conclusion: These findings suggest that Vedistry Arjuna + Tablet possesses antihyper-lipidemic, antihypertensive, and cardiac function improving activities.